Adjusting therapy to cardiovascular risk status

American Journal of Medicine

Volumn 107, Issue 2 SUPPL. 1, 1999, Pages 31-33

  Pasternak, Richard C ^a  

^a Prev Cardiol Cardiology Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; CONFERENCE PAPER; HUMAN; ISCHEMIC HEART DISEASE; MATHEMATICAL MODEL; PREDICTION; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SECONDARY PREVENTION; CORONARY ARTERY DISEASE; PREDICTION AND FORECASTING; REVIEW; RISK; CARDIOVASCULAR DISEASE; FOLLOW UP; MEDICAL DECISION MAKING; POPULATION RESEARCH; RISK MANAGEMENT;

CORONARY DISEASE; HUMANS; PREDICTIVE VALUE OF TESTS; RISK; RISK FACTORS;

EID: 0032844083     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00151-5     Document Type: Conference Paper

References (7)

1. Greenland P., Grundy S., Pasternak R.C., Lenfant C. Problems on the pathway from risk assessment to risk reduction. Circulation. 97:1998;1761-1762.
2. Houston-Miller N., Hill M., Kottke T., Ockene I.S. The multilevel compliance challenge recommendations for a call to action - a statement for healthcare professionals . Circulation. 95:1997;1085-1090.
3. Wilson P.W.F., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation. 97:1998;1837-1847.
4. Grundy S.M., Balady G.J., Criqui M.H., et al. Primary prevention of coronary heart disease guidance from Framingham. A statement for healthcare professionals from the AHA Task Force on Risk Reduction . Circulation. 97:1998;1876-1887.
5. Moriarty P.M. Relative risk reduction versus number needed to treat as measures of lipid-lowering trial results. Am J Cardiol. 82:1998;505-507.
6. Califf R.M., Armstrong P.W., Carver J.R., D'Agostino R.B., Strauss W.E. Task Force 5 stratification of patients into high, medium and low risk subgroups for purposes of risk factor management . J Am Coll Cardiol. 27:1996;1007-1019.
7. Summary of the second report. JAMA. 269:1993;3015-3023.